Invitae Reproductive Health→Natera
Asset Acquisition · Cash (asset acquisition) · NTRA · announced Jan 22, 2024
Announced
Jan 22, 2024
Closed
Jan 22, 2024
Economics
Cash (asset acquisition)()
Pre-deal · pre-deal mark: 2024, year precision · Natera 8-K filing, SEC EDGAR — Invitae asset acquisition
$10M upfront + up to $42.5M milestones (cash + litigation credits)
Target
Invitae Reproductive Health
Diagnostics · Diagnostic / genomic
HQ San Francisco, CA · Founded 2012
Non-invasive prenatal screening (NIPS) and carrier screening business — divested reproductive health assets from Invitae's broader genetic testing portfolio
- Business Wire — Natera press release (Jan 22, 2024)
- Natera investor relations
Acquirer
Natera (NTRA)
Diagnostics
HQ Austin, TX
Why this buyer
Curated copy from the verified dataset — not an 8-K LLM summary
Acquired Invitae's NIPS and carrier screening customers — consolidates prenatal/reproductive cfDNA testing market under Natera's platform
Evidence ladder
Secondary (press / IR)
Business Wire — Natera press release (Jan 22, 2024)
Limitations
- Single-source or weak corroboration — treat valuation and timing as directional.
- $10M upfront + up to $42.5M milestones (cash + litigation credits)
- Pre-deal valuation sourced from: Natera 8-K filing, SEC EDGAR — Invitae asset acquisition. Pre-deal market-cap and funding citations do not corroborate the acquisition.
Patient empowerment context
Empowerment context — Invitae Reproductive Health
Curated survey mappingHLTH/Outcomes4Me 2022 surveyed breast cancer patients (n=1,828). Breast cancer care continuum (HLTH 2022). Rows below are analyst-curated mappings to cited survey items — not live patient outcomes for this target.
- Not recommended genetic testing (NCCN: almost all should)37%cited HLTH 2022
Other curated mappings on these gaps: Biotheranostics, Endomagnetics, Genomic Health, Foundation Medicine
Full cited gap matrix →Related verified workspaces
Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.
Curated verified dataset v9 · updated 2026-09-20 · 1 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.